Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-05-20

Clinical Trial Update: Fat Emulsion in Preventing Hypersensitivity Reactions in Patients With Cancer Receiving Carboplatin or Oxaliplatin [NA]

View source ↗

Summary

This completed clinical trial evaluated whether a fat emulsion can prevent hypersensitivity reactions in cancer patients receiving carboplatin or oxaliplatin; r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CARBOPLATIN (Carboplatin)
  • Intralipid Fat Emulsion (lipid emulsion)
  • OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Mayo Clinic | Conditions: Advanced Malignant Neoplasm | NA | Status: COMPLETED | Results posted: 2020-05-20